Amicus Therapeutics Inc (NASDAQ:FOLD)

11.39
Delayed Data
As of May 22
 0.00 / 0.00%
Today’s Change
2.01
Today|||52-Week Range
13.20
+36.90%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Amicus Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for the treatment of rare diseases, pharmacological chaperones are a novel, first-in-class approach to treating a broad range of diseases, including lysosomal storage disorders and diseases of neurodegeneration. Amicus develops pharmacological chaperones oral therapies that bind to and stabilize the affected proteins, restoring their shape, proper trafficking, and biological activity. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.

Contact Information

Amicus Therapeutics, Inc.
1 Cedar Brook Drive
Cranbury New Jersey 08512
P:(609) 662-2000
Investor Relations:
(609) 662-5044

Employees

Shareholders

Other institutional67.68%
Individual stakeholders46.61%
Mutual fund holders24.23%

Top Executives

John Francis CrowleyChairman & Chief Executive Officer
Bradley L. CampbellPresident & Chief Operating Officer
William D. BairdChief Financial Officer
Enrique DiloneVice President-Technical Operations
Robert E. WinklerVice President-Clinical Research & Operations

To view my watchlist

Not a member yet?

Sign up now for a free account